Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2
1(100.0%)
1Total
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06528340Completed

Pregnancies Outcomes in Advanced Maternal Age Women

Role: lead

NCT06474065Completed

Pregnancy Outcomes Following Myomectomy

Role: lead

NCT06768086Completed

Preoperative Administration of EGCG, Vitamin D and DCI Prior Hysteroscopic Myomectomy

Role: lead

NCT06664112Recruiting

Delivery Outcomes by AIDA (Artificial Intelligence Dystocia Algorithm) Analysis

Role: lead

NCT06098456Phase 2Completed

Epigallocatechin Gallate and Other Antural Compounds in HPV Infections

Role: lead

All 5 trials loaded